“Is a four-week hormone suspension necessary for thyroid remnant ablation in low and intermediate risk patients? A pilot study with quality-of-life assessment”, Braz. J. Rad. Sci., vol. 10, no. 4, pp. 1–16, Dec. 2022, doi: 10.15392/2319-0612.2022.2047.